## Abstract Dolasetron is a 5βhydroxytryptamine antagonist active at type III receptors; it is presently undergoing clinical evaluation for the reduction/prevention of cancer chemotherapyinduced nausea and vomiting. A previous study demonstrated that following intravenous administration to healthy
Dose-dependent disposition of oral propranolol in normal subjects
β Scribed by Janis J. Mackichan; Dennis R. Pyszczynski; William J. Jusko
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 376 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The pharmacokinetics and relative systemic availability or oral propranolol were studied in three healthy volunteers following administration of 10, 40, and 80 mg of propranolol hydrochloride. Plasma concentrations of propranolol were determined using a sensitive and specific fluorometric high pressure liquid chromatographic technique. In the dosage range studied, the amount of propranolol reaching the systemic circulation increased with dose, while halfβlives remained unchanged. The apparent βthreshold doseβ for propranolol was much smaller than previously reported, and its contribution to the observed doseβdependent availability is doubtful. Apparent intrinsic clearance values were shown to decrease with increase in dose, with a true maximal intrinsic clearance of 5Β·4 1kg^β1^ h^β1^. These data suggest the saturation of a low capacity enzyme system in the liver and are consistent with theoretical characteristics of a drug that is extensively metabolized during its first pass through the liver.
π SIMILAR VOLUMES
Four normal volunteers each received two intravenous doses o f PA. The mean low dose was 3.30 mg kg-' (infused over 20 minutes) while the mean high dose was 12.5 mg kg-' (infused over 60 minutes). Blood samples were collected for 12 hours and urine was collected for 48 hours after each dose. PA conc
Mean minimum quantifiable level (MQL) was 0.01 K g / g . \* No sample.
The pharmacokinetics of fluvoxamine after single oral administration of 25, 50, and 100mg fluvoxamine maleate was studied in a three-way cross-over study in 12 healthy male subjects. Fluvoxamine was administered orally in a solution. For doseproportionality, AUC, and C,-dose relationships were evalu